156 related articles for article (PubMed ID: 8224263)
1. Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation.
Salat-Baroux J; Rotten D; Alvarez S; Antoine JM
Fertil Steril; 1993 Nov; 60(5):791-9. PubMed ID: 8224263
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of growth hormone and gonadotropins in achieving conception in "clonidine-negative" patients with unexplained infertility.
Blumenfeld Z; Amit T; Barkey RJ; Lunenfeld B; Brandes JM
Ann N Y Acad Sci; 1991; 626():250-65. PubMed ID: 1905509
[TBL] [Abstract][Full Text] [Related]
3. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women.
Hugues JN; Torresani T; Herve F; Martin-Pont B; Tamboise A; Santarelli J
Fertil Steril; 1991 May; 55(5):945-51. PubMed ID: 1827076
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone responses to growth hormone-releasing hormone, clonidine and insulin-induced hypoglycemia in normal weight bulimic women.
Coiro V; Capretti L; Volpi R; d'Amato L; Marchesi C; De Ferri A; Rossi G; Bianconi L; Marcato A; Chiodera P
Neuropsychobiology; 1990; 23(1):8-14. PubMed ID: 2126361
[TBL] [Abstract][Full Text] [Related]
5. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
7. Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells.
Tapanainen J; Martikainen H; Voutilainen R; Orava M; Ruokonen A; Rönnberg L
Fertil Steril; 1992 Oct; 58(4):726-32. PubMed ID: 1426317
[TBL] [Abstract][Full Text] [Related]
8. The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man.
Suri D; Hindmarsh PC; Brain CE; Pringle PJ; Brook CG
Clin Endocrinol (Oxf); 1990 Sep; 33(3):399-406. PubMed ID: 2147600
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P
J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
[TBL] [Abstract][Full Text] [Related]
10. Growth Hormone Supplementation in the Luteal Phase Before Microdose GnRH Agonist Flare Protocol for In Vitro Fertilization.
Dunne C; Seethram K; Roberts J
J Obstet Gynaecol Can; 2015 Sep; 37(9):810-815. PubMed ID: 26605451
[TBL] [Abstract][Full Text] [Related]
11. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
Mota A; Bento A; Peñalva A; Pombo M; Dieguez C
J Clin Endocrinol Metab; 1995 Jun; 80(6):1973-7. PubMed ID: 7775648
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.
Tancer ME; Stein MB; Uhde TW
Psychoneuroendocrinology; 1990; 15(4):253-9. PubMed ID: 2087535
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) responses to GH-releasing hormone in depression: correlation with GH release following clonidine.
Lesch KP; Laux G; Erb A; Pfüller H; Beckmann H
Psychiatry Res; 1988 Sep; 25(3):301-10. PubMed ID: 3141943
[TBL] [Abstract][Full Text] [Related]
14. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol.
Schoolcraft W; Schlenker T; Gee M; Stevens J; Wagley L
Fertil Steril; 1997 Jan; 67(1):93-7. PubMed ID: 8986690
[TBL] [Abstract][Full Text] [Related]
15. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
[TBL] [Abstract][Full Text] [Related]
16. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
Ghigo E; Bellone J; Aimaretti G; Bellone S; Loche S; Cappa M; Bartolotta E; Dammacco F; Camanni F
J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone responses to growth hormone-releasing hormone and clonidine in patients with type I diabetes and in normal controls: effect of age, body mass index and sex.
Jacobs ML; Nathoe HM; Blankestijn PJ; Stijnen T; Weber RF
Clin Endocrinol (Oxf); 1996 May; 44(5):547-53. PubMed ID: 8762731
[TBL] [Abstract][Full Text] [Related]
19. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Cordido F; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
[TBL] [Abstract][Full Text] [Related]
20. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
